# Liver-derived Indian hedgehog (Ihh) couples fast-feed transition to thermogenic and metabolic homeostasis

## TL;DR

The liver releases a protein called Ihh during feeding, which helps control body metabolism and could be a new target for treating obesity and diabetes.

## Contribution

Ihh is identified as a novel liver-derived hepatokine that links feeding patterns to metabolic health through thermogenesis and glucose regulation.

## Key findings

- Ihh promotes adipose thermogenesis and metabolic flexibility upon feeding.
- Liver PRC2 represses Ihh via a bivalent chromatin state, and its deletion protects against obesity.
- Human Ihh-VLDL levels decline with age and correlate with improved metabolic parameters.

## Abstract

Obesity and type 2 diabetes are global health challenges driven by genetic and environmental factors, including diet. While intermittent fasting improves metabolic health, the hepatic mechanisms linking feeding transitions to systemic metabolic regulation remain unclear. We investigated whether Indian Hedgehog (Ihh), a liver-derived hepatokine, coordinates metabolic responses to nutritional transitions.

We employed genetic and epigenetic tools, including liver-specific deletion of the PRC2 component Eed, to study Ihh regulation. In vivo metabolic phenotyping, thermogenic gene profiling, and Ihh immunoneutralization assessed its function. VLDL-associated Ihh levels were measured and their correlations with metabolic traits were analyzed in humans.

Ihh is induced upon feeding and promotes adipose thermogenesis, enhancing metabolic flexibility. The Ihh locus in hepatocytes resides in a bivalent chromatin state; hepatic Eed deletion derepresses Ihh, conferring resistance to diet-induced obesity and insulin resistance. Immunoneutralization of Ihh reverses this protection, confirming its necessity. Ihh circulates in complex with VLDL. Human Ihh-VLDL levels decline with age and correlate with improved metabolic parameters, including insulin sensitivity, HDL/LDL ratio, and reduced adiposity.

Ihh is a liver-derived, epigenetically regulated hepatokine that links nutrient timing to systemic metabolic control by stimulating thermogenesis and promoting glucose homeostasis. These findings identify Ihh as a key inter-organ signal coupling hepatic chromatin dynamics to energy balance. The age-related decline in circulating Ihh and its strong association with metabolic health suggest that enhancing Ihh signaling may represent a novel therapeutic avenue for obesity and type 2 diabetes.

•Ihh is a novel hepatokine induced during feeding that promotes thermogenesis.•Liver PRC2 represses Ihh via a poised bivalent chromatin state.•Hepatic Ihh overexpression protects against obesity and insulin resistance.•Ihh is secreted in VLDL and correlates with metabolic health in humans.•Ihh links nutrient timing to inter-organ metabolic coordination.

Ihh is a novel hepatokine induced during feeding that promotes thermogenesis.

Liver PRC2 represses Ihh via a poised bivalent chromatin state.

Hepatic Ihh overexpression protects against obesity and insulin resistance.

Ihh is secreted in VLDL and correlates with metabolic health in humans.

Ihh links nutrient timing to inter-organ metabolic coordination.